July 17, 2024

AbTherx Appoints Pallavi Tawde, PhD, as Head of Preclinical R&D...

Former Pfizer, BMS, and Denali scientific leader to lead expansion of antibody discovery, preclinical development, and early clinical capabilities Foster City, Calif.... Read More »

June 18, 2024

AbTherx Opens Antibody Discovery Technologies Research Center

New research center’s world-class antibody discovery capabilities support a growing portfolio of Atlas™ Mice transgenic technologies and partnerships Foster City, Cal... Read More »

May 9, 2024

The Jackson Laboratory and AbTherx Announce Partnership to Enhance Therapeutic...

Bar Harbor, Maine and Mountain View, California – May 9, 2024 – The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx,... Read More »

March 20, 2024

AbTherx Appoints Jessica Stark, PhD, as Scientific Advisor

Glycoimmunology expert and co-inventor of AbLec technology joins AbTherx to expand expertise around challenging drug targets Mountain View, Calif. – March 20, 2024 – ... Read More »

March 13, 2024

AbTherx Partners with Single Cell Technology for First Antibody Discovery...

Partnership provides AbTherx and licensees of AbTherx’s Atlas™ Mice access to Single Cell Technology’s proprietary single B cell screening engine Mountain View ... Read More »

View All News